Tech News articles are straightforward news stories. They provide facts and details about happenings, announcements, and events in Utah's tech sector that the TechBuzz editor and founders consider newsworthy and important for the ecosystem to be aware of.
Tech News
Tech News articles are straightforward news stories. They provide facts and details about happenings, announcements, and events in Utah's tech sector that the TechBuzz editor and founders consider newsworthy and important for the ecosystem to be aware of.
PhotoPharmics (American Fork, UT) completes enrollment in its 350-participant, fully remote Phase 3 trial testing the Celeste® light-therapy device for Parkinson’s, a non-drug, home-based treatment targeting non-motor symptoms through photo-neuromodulation.
PhotoPharmics (American Fork, UT) completes enrollment in its 350-participant, fully remote Phase 3 trial testing the Celeste® light-therapy device for Parkinson’s, a non-drug, home-based treatment targeting non-motor symptoms through photo-neuromodulation.
Palladyne AI, formerly Sarcos Robotics (Salt Lake City, UT), has transformed from building exoskeletons to developing embodied AI software powering autonomous drones and robots, securing Air Force contracts, key patents, and a growing defense-tech footprint.
Palladyne AI, formerly Sarcos Robotics (Salt Lake City, UT), has transformed from building exoskeletons to developing embodied AI software powering autonomous drones and robots, securing Air Force contracts, key patents, and a growing defense-tech footprint.
PhotoPharmics (American Fork, UT) completes enrollment in its 350-participant, fully remote Phase 3 trial testing the Celeste® light-therapy device for Parkinson’s, a non-drug, home-based treatment targeting non-motor symptoms through photo-neuromodulation.
PhotoPharmics (American Fork, UT) completes enrollment in its 350-participant, fully remote Phase 3 trial testing the Celeste® light-therapy device for Parkinson’s, a non-drug, home-based treatment targeting non-motor symptoms through photo-neuromodulation.
Everee (Salt Lake City, UT) has launched the Flex Platform, enabling real-time, compliant payroll without fixed pay cycles. The system automates payments as work is completed, improving speed, flexibility, and worker retention.
Everee (Salt Lake City, UT) has launched the Flex Platform, enabling real-time, compliant payroll without fixed pay cycles. The system automates payments as work is completed, improving speed, flexibility, and worker retention.
Thera-T Pharmaceutics (Salt Lake City, UT), develops a two-component, AI-guided T cell therapy, targeting multiple cancer markers while reducing toxicity—earning the University of Utah’s 2025 Breakthrough Technology of the Year award.
Thera-T Pharmaceutics (Salt Lake City, UT), develops a two-component, AI-guided T cell therapy, targeting multiple cancer markers while reducing toxicity—earning the University of Utah’s 2025 Breakthrough Technology of the Year award.
Vector (Bluffdale, UT), led by former Army aviator Andy Yakulis, secures a multi-million SOCOM contract, providing attritable drones via a subscription “Modern Warfare as a Service” model, with fiber-optic FPV integration, tactical training, and battlefield innovation showcased at the 47G Summit.
